dc.creator | Savulescu, J. | en |
dc.creator | Foddy, B. | en |
dc.creator | Clayton, M. | en |
dc.date.accessioned | 2016-01-08T23:47:43Z | en |
dc.date.available | 2016-01-08T23:47:43Z | en |
dc.date.created | 2004-12-01 | en |
dc.date.issued | 2004-12-01 | en |
dc.identifier | doi:10.1136/bjsm.2003.005249 | en |
dc.identifier.bibliographicCitation | British Journal of Sports Medicine 2004 December 1; 38(6): 666-670 | en |
dc.identifier.uri | http://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Why+we+should+allow+performance+enhancing+drugs+in+sport&title=British+Journal+of+Sports+Medicine+&volume=38&issue=6&spage=666-670&date=2004-12&au=Savulescu,+J.;+Foddy,+B.;+Clayton,+M. | en |
dc.identifier.uri | http://dx.doi.org/10.1136/bjsm.2003.005249 | en |
dc.identifier.uri | http://hdl.handle.net/10822/986244 | en |
dc.format | Article | en |
dc.language | en | en |
dc.source | eweb:278516 | en |
dc.subject | Drugs | en |
dc.subject.classification | Drugs and Drug Industry | en |
dc.subject.classification | Health Care for Particular Diseases or Groups | en |
dc.title | Why We Should Allow Performance Enhancing Drugs in Sport | en |
dc.provenance | Citation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database. | en |
dc.provenance | Citation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown. | en |